Please try another search
BeiGene, Ltd., through its subsidiaries, engages in the development and commercialization of oncology medicines worldwide. Its products include BRUKINSA to treat various blood cancers; TEVIMBRA to treat various solid tumor and blood cancers; PARTRUVIX for the treatment of various solid tumor malignancies; XGEVA to treat bone metastases from solid tumors and multiple myeloma, as well as giant cell tumor of bone; BLINCYTO to treat acute lymphoblastic leukemia; KYPROLIS to treat R/R multiple myeloma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplastic syndromes, chronic myelomonocyte leukemia, and acute myeloid leukemia; SYLVANT to treat idiopathic multicentric castleman disease; QARZIBA to treat neuroblastoma; POBEVCY to treat metastatic colorectal cancer, liver cancer, and non-small cell lung cancer (NSCLC); BAITUOWEI, to treat breast and prostate cancers; TAFINLAR and MEKINIST to treat NSCLC and melanoma; VOTRIENT for advance renal cell carcinoma; AFINITOR for advance renal cell carcinoma, NET, SEGA, & breast cancers; and ZYKADIA to treat ALK + NSCLC. The company is also developing inhibitors comprising Sonrotoclax (BGB-11417), BGB-10188, BGB-21447, Ociperlimab (BGB-A1217), Surzebiclimab (BGB-A425), BGB-15025, BGB-26808, Lifirafenib (BGB-283), BGB-3245, BGB-30813, and BGB-43395; antibodies, including Zanidatamab, BGB-A445, and BGB-A3055, as well as BGB-16673, a BTK-targeted CDAC, and BGB-24714, a SMAC mimetic. It has collaborations with Shoreline Biosciences, Inc., Amgen Inc., Novartis AG, Bristol Myers Squibb company, Shandong Luye Pharmaceutical Co., Ltd., Nanjing Leads Biolabs, Inc., EUSA Pharma, Assembly Biosciences, Inc., Bio-Thera Solutions, Ltd., and Nanjing Leads Biolabs Co., Ltd. The company was incorporated in 2010 and is based in Grand Cayman, the Cayman Islands.
Name | Age | Since | Title |
---|---|---|---|
Xiaodong Wang | 61 | 2010 | Co- Chairman of Scientific Advisory Board & Non-Executive Director Co-Founder |
John V. Oyler | 56 | 2010 | Co-Founder, Executive Chairman & CEO |
Michael J. Goller | 49 | 2015 | Independent Non-Executive Director & Member of the Scientific Advisory Committee |
Ranjeev Krishana | 50 | 2014 | Independent Lead Director |
Donald Wayne Glazer | 80 | 2013 | Independent Non-Executive Director |
Michael Qingqing Yi | - | - | Independent Non-Executive Director & Co-Chairman Advisory Committe |
Alessandro Riva | 63 | 2022 | Co-Chairman of Scientific Advisory Committee & Independent Non-Executive Director |
Margaret Han Dugan | 67 | 2022 | Member of Scientific Advisory Board & Independent Non-Executive Director |
Anthony C. Hooper | 69 | 2020 | Independent Non-Executive Director |
Corazon Dating Sanders | 67 | 2020 | Independent Non-Executive Director & Member of Scientific Advisory Committee |
Olivier Brandicourt | 68 | 2024 | Independent Non-Executive Director |
Steven Young | - | 2021 | Acting Head of Medicinal Chemistry & Member of Scientific Advisory Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review